As compared with venous plasma testing, point-of-care INR measuring devices allow greater testing frequency and patient involvement and may improve clinical outcomes. We randomly assigned 2922 ...

self-testing device for coagulation monitoring, this summer. The new system will allow patients to monitor International Normalized Ratio (INR) and send results wirelessly to healthcare providers ...

EMA started investigating this issue as soon as it was informed of the defect in the INR device by the marketing authorisation holder of Xarelto, Bayer Pharma AG, in September 2015.

However, controversy has surrounded the international normalized ratio (INR) measuring device used in the trial to monitor warfarin administration. The Alere INRatio Monitor System was part of a ...

The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...

But it said in the document that "validation studies designed exclusively for demonstrating equivalence between plasma-based devices and POC (point-of-care) PT/INR devices may not be sufficient ...